JoVE Logo
Faculty Resource Center

Sign In

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

DOI :

10.3791/56326-v

8:14 min

October 26th, 2017

October 26th, 2017

15,076 Views

1Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 2Unit of Thoracic Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori

Here, we present the detailed protocol adopted in the BioMILD screening trial to perform the circulating microRNA signature classifier test for early lung cancer detection.

Tags

MicroRNA

-- Views

Related Videos

article

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

article

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

article

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

article

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

article

Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue

article

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

article

Perfusion and Inflation of the Mouse Lung for Tumor Histology

article

Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells

article

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

article

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved